These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 17485241)

  • 21. Lamotrigine-valproic acid combination therapy for medically refractory epilepsy.
    Moeller JJ; Rahey SR; Sadler RM
    Epilepsia; 2009 Mar; 50(3):475-9. PubMed ID: 19054403
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sodium valproate versus lamotrigine: a randomised comparison of efficacy, tolerability and effects on circulating androgenic hormones in newly diagnosed epilepsy.
    Stephen LJ; Sills GJ; Leach JP; Butler E; Parker P; Hitiris N; Leach VM; Wilson EA; Brodie MJ
    Epilepsy Res; 2007 Jul; 75(2-3):122-9. PubMed ID: 17553671
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The clinical efficacy of lamotrigine as an antiepileptic drug.
    Pellock JM
    Neurology; 1994 Nov; 44(11 Suppl 8):S29-35. PubMed ID: 7970004
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lamotrigine-induced lupus-like syndrome: a case report and literature review.
    Chang RS; Cole AJ
    Am J Ther; 2014; 21(3):e85-7. PubMed ID: 23011169
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Once-daily lamotrigine extended release for epilepsy management.
    Rheims S; Ryvlin P
    Expert Rev Neurother; 2009 Feb; 9(2):167-73. PubMed ID: 19210192
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurophysiologic and neuropsychologic profiles of lamotrigine in epilepsy.
    Marciani MG; Spanedda F; Mattia D
    Clin Neuropharmacol; 1999; 22(3):159-63. PubMed ID: 10367180
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Lamotrigine in the adult-onset epilepsy: efficacy and long-term safety].
    Alegre M; Iriarte J; Schlumberger E; Urrestarazu E; Lázaro D; Viteri C
    Neurologia; 2002 Mar; 17(3):136-42. PubMed ID: 11927102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological outcomes in newly diagnosed epilepsy.
    Mohanraj R; Brodie MJ
    Epilepsy Behav; 2005 May; 6(3):382-7. PubMed ID: 15820347
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of lamotrigine in idiopathic generalized epilepsy syndromes: a video-EEG-controlled, open study.
    Gericke CA; Picard F; de Saint-Martin A; Strumia S; Marescaux C; Hirsch E
    Epileptic Disord; 1999 Sep; 1(3):159-65. PubMed ID: 10937148
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Routine use of lamotrigine, a new anti-epileptic medication, and the value of measuring its blood levels.
    Beran RG; Sheehan K; Tilley MI
    Clin Exp Neurol; 1994; 31():61-7. PubMed ID: 7586666
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypersexuality in two patients with epilepsy treated with lamotrigine.
    Grabowska-Grzyb A; Nagańska E; Wolańczyk T
    Epilepsy Behav; 2006 May; 8(3):663-5. PubMed ID: 16473556
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of lamotrigine add-on therapy in severe partial epilepsy in adults with drop seizures and secondary bilateral synchrony on EEG.
    Bisulli F; Baruzzi A; Rosati A; Riva R; Avoni P; Cerullo A; Tinuper P
    Epileptic Disord; 2001 Sep; 3(3):151-6. PubMed ID: 11679308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lamotrigine and catamenial epilepsy.
    Gilad R; Sadeh M; Rapoport A; Dabby R; Lampl Y
    Seizure; 2008 Sep; 17(6):531-4. PubMed ID: 18420429
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term profile of lamotrigine in 119 children with epilepsy.
    Brodbeck V; Jansen V; Fietzek U; Muehe C; Weber G; Heinen F
    Eur J Paediatr Neurol; 2006 May; 10(3):135-41. PubMed ID: 16759890
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improved mood states with lamotrigine in patients with epilepsy.
    Cramer JA; Hammer AE; Kustra RP
    Epilepsy Behav; 2004 Oct; 5(5):702-7. PubMed ID: 15380122
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term effectiveness of ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy.
    Hwang H; Kim H; Kim SH; Kim SH; Lim BC; Chae JH; Choi JE; Kim KJ; Hwang YS
    Brain Dev; 2012 May; 34(5):344-8. PubMed ID: 21893390
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vulnerability of an epileptic case to psychosis: sodium valproate with lamotrigine, forced normalization, postictal psychosis or all?
    Turan AB; Seferoglu M; Taskapilioglu O; Bora I
    Neurol Sci; 2012 Oct; 33(5):1161-3. PubMed ID: 22131039
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term retention rates of new antiepileptic drugs in adults with chronic epilepsy and learning disability.
    Simister RJ; Sander JW; Koepp MJ
    Epilepsy Behav; 2007 Mar; 10(2):336-9. PubMed ID: 17267290
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lamotrigine therapy of epilepsy with Angelman's syndrome.
    Dion MH; Novotny EJ; Carmant L; Cossette P; Nguyen DK
    Epilepsia; 2007 Mar; 48(3):593-6. PubMed ID: 17326790
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
    Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
    Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.